APE1 — AP Endonuclease 1

Migration, Crosslink

📖

APE1 — AP Endonuclease 1

active

wiki page Created: 2026-04-02T07:19:17 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ape1

📖 Wiki Page

gene2083 wordssynced 2026-04-02

APE1 — AP Endonuclease 1

<div class="infobox infobox-gene">
<div class="infobox-header">APE1 — AP Endonuclease 1</div>

Overview

<div is a human gene whose product aPE1 (Apurinic/Apyrimidinic Endonuclease 1)** is a essential DNA repair enzyme that plays a critical role in the base excision repair (BER) pathway. It recognizes and cleaves apurinic/apyrimidinic (AP) sites in DNA that arise spontaneously or from oxidative damage. APE1 also has redox function (Ref-1) regulating transcription factor activity including AP-1, NF-κB, p53, and HIF-1α[@tell2009]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

<table>
<tr><th>Symbol</th><td><strong>APE1</strong></td></tr>
<tr><th>Full Name</th><td>Apurinic/Apyrimidinic Endonuclease 1</td></tr>
<tr><th>Chromosomal Location</th><td>14q11.2</td></tr>
<tr><th>NCBI Gene ID</th><td>https://www.ncbi.nlm.nih.gov/gene/328 328</td></tr>
<tr><th>OMIM</th><td>https://www.omim.org/entry/107323 107323</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100823</td></tr>
<tr><th>UniProt</th><td>https://www.uniprot.org/uniprot/P27695 P27695</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr>
</table>
</div>

Function

...

APE1 — AP Endonuclease 1

<div class="infobox infobox-gene">
<div class="infobox-header">APE1 — AP Endonuclease 1</div>

Overview

<div is a human gene whose product aPE1 (Apurinic/Apyrimidinic Endonuclease 1)** is a essential DNA repair enzyme that plays a critical role in the base excision repair (BER) pathway. It recognizes and cleaves apurinic/apyrimidinic (AP) sites in DNA that arise spontaneously or from oxidative damage. APE1 also has redox function (Ref-1) regulating transcription factor activity including AP-1, NF-κB, p53, and HIF-1α[@tell2009]. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

<table>
<tr><th>Symbol</th><td><strong>APE1</strong></td></tr>
<tr><th>Full Name</th><td>Apurinic/Apyrimidinic Endonuclease 1</td></tr>
<tr><th>Chromosomal Location</th><td>14q11.2</td></tr>
<tr><th>NCBI Gene ID</th><td>https://www.ncbi.nlm.nih.gov/gene/328 328</td></tr>
<tr><th>OMIM</th><td>https://www.omim.org/entry/107323 107323</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100823</td></tr>
<tr><th>UniProt</th><td>https://www.uniprot.org/uniprot/P27695 P27695</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr>
</table>
</div>

Function

APE1 (Apurinic/Apyrimidinic Endonuclease 1) is a essential DNA repair enzyme that plays a critical role in the base excision repair (BER) pathway. It recognizes and cleaves apurinic/apyrimidinic (AP) sites in DNA that arise spontaneously or from oxidative damage. APE1 also has redox function (Ref-1) regulating transcription factor activity including AP-1, [NF-κB](/mechanisms/nf-kb-pathway), p53, and HIF-1α[@tell2009].

Base Excision Repair (BER) Pathway

APE1 is the central enzyme in the base excision repair (BER) pathway, which handles small, non-bulky DNA lesions caused by oxidative damage, alkylation, and deamination[@caldecott2020]:

Lesion recognition: DNA glycosylases (e.g., OGG1, NTH1, MUTYH) recognize and remove damaged bases, creating AP sites

AP site cleavage: APE1 nicks the DNA backbone 5' to the AP site, creating a single-strand break with a 5'-deoxyribose phosphate (5'-dRP) moiety

DNA polymerase β: Fills in the missing nucleotide and removes the 5'-dRP flap

DNA ligase: Seals the nick, completing repair

APE1's endonuclease activity is essential—without it, AP sites accumulate, leading to strand breaks, genomic instability, and [cell death](/mechanisms/cell-death-pathways).

Redox Function (Ref-1)

Beyond DNA repair, APE1's N-terminal domain possesses redox activity, functioning as a "redox factor-1" (Ref-1)[@demple2019]. This activity:

Reduces oxidized cysteine residues in transcription factors, maintaining their DNA-binding activity
Regulates [AP-1](/mechanisms/ap-1-signaling) (c-Fos/c-Jun), [NF-κB](/mechanisms/nf-kb-pathway), p53, HIF-1α, and ATF4
Links cellular redox state to gene expression programs
Is protective in neurodegeneration by maintaining pro-survival transcription[@fung2021]

The dual functionality makes APE1 unique: a "two-faced" protein balancing genomic stability and transcriptional regulation.

Mitochondrial DNA Repair

APE1 localizes to both nucleus and mitochondria, where it performs essential mitochondrial DNA (mtDNA) repair. Dopaminergic neurons have high metabolic demands and are particularly vulnerable to mtDNA damage. APE1 deficiency in mitochondria contributes to:

Accumulation of oxidative mtDNA lesions in [Parkinson's Disease](/diseases/parkinsons-disease)
Mitochondrial dysfunction and [neuronal death](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
Impaired mitophagy and [energy crisis](/mechanisms/energy-dysfunction-parkinsons)

Disease Associations

APE1 dysfunction is central to multiple neurodegenerative diseases due to its essential role in DNA repair and redox regulation.

Alzheimer's Disease

APE1 deficiency contributes to accumulation of oxidative DNA damage in [neurons](/cell-types/neurons)[@copped2011]. Key mechanisms include:

Reduced APE1 activity in AD brain tissue, particularly in [hippocampus](/brain-regions/hippocampus) and [entorhinal cortex](/brain-regions/entorhinal-cortex)
Oxidative stress increases AP site formation; without adequate APE1, damage accumulates
p53 dysregulation — APE1's redox regulation of p53 is impaired, affecting [apoptosis](/mechanisms/cellular-apoptosis-pathways) decisions
β-amyloid toxicity downregulates APE1 expression, creating a vicious cycle[@thakur2019]

Parkinson's Disease

APE1 polymorphisms associated with PD risk. Important for repair of mitochondrial DNA damage in dopaminergic neurons:

Mitochondrial vulnerability — dopaminergic neurons rely on APE1 for mtDNA repair
α-synuclein interaction — pathological alpha-synuclein can interfere with APE1's DNA binding and repair function
LRRK2 connection — LRRK2 kinase activity may modulate APE1 function; G2019S mutations affect DNA damage responses
Environmental toxins (e.g., MPTP, rotenone) increase oxidative DNA damage requiring APE1

Amyotrophic Lateral Sclerosis (ALS)

Oxidative DNA damage accumulation in motor neurons:

Elevated 8-oxoguanine (8-oxoG) lesions in ALS spinal cord
Reduced APE1 expression in motor neurons
Connection to SOD1 mutations and oxidative stress
FUS and TDP-43 pathology affects DNA damage response pathways

Huntington's Disease

CAG repeat expansion requires efficient DNA repair; APE1 dysfunction accelerates expansion
Transcriptional dysregulation via impaired Ref-1 function
Energy deficits compound DNA repair deficiencies

Aging and Genomic Instability

APE1 activity declines with age, contributing to genomic instability and neurodegeneration:

Age-related decline in APE1 expression and activity
Accumulation of somatic mutations in neurons
Link to [cellular senescence](/mechanisms/cellular-senescence-neurodegeneration)

Expression

Broad expression throughout the brain, with high levels in neurons. Subcellular localization: nucleus and mitochondria. Expression is upregulated in response to oxidative stress.

Cell-Type Specificity

Neurons: High APE1 expression; essential for maintaining genomic integrity in post-mitotic cells
Astrocytes: Moderate expression; supports glial DNA repair capacity
Microglia: Inducible expression in response to neuroinflammation
Oligodendrocytes: Important for myelin sheath maintenance; vulnerability in HD and AD

Regulation

Transcriptional: p53-dependent activation in response to DNA damage
Post-translational: Phosphorylation, acetylation, and oxidation modulate activity
Subcellular targeting: Alternative splicing and mitochondrial targeting sequences

Protein Structure

APE1 is a 36 kDa protein with two functional domains:

N-terminal domain (1-80 aa): Redox-active; contains cysteine residues (Cys65, Cys93) for Ref-1 function
C-terminal domain (80-318 aa): Endonuclease catalytic core; contains the active site (His309, Asp283, Glu96)

Active Site Architecture

The catalytic site uses a metal-dependent mechanism (Mg²⁺) to cleave the phosphodiester bond 5' to AP sites. The active site His309 acts as a general acid/base, while Asp283 coordinates the metal ion.

Therapeutic Implications

APE1 represents a promising therapeutic target for neurodegenerative diseases[@shah2015]:

Small-Molecule Activators

E3330 (APX-3330): First-in-class APE1/Ref-1 redox inhibitor (being developed for cancer, but has neuroprotective potential)
Redox modulators: Compounds that enhance APE1's Ref-1 function may protect neurons

Gene Therapy Approaches

AAV-mediated APE1 overexpression for targeted delivery to affected brain regions
Mitochondrial-targeted APE1 for enhanced mtDNA repair

Combination Strategies

APE1 activation + antioxidant therapy (e.g., CoQ10, NAC)
APE1 + PARP inhibitors for synthetic lethality in stressed neurons
DNA repair boosting + mitochondrial function enhancement

Key Publications

[Fung et al., APE1/Ref-1 in neurodegeneration (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.03.012)

[Thakur et al., APE1 and Alzheimer's disease (2019)](https://doi.org/10.1007/s12017-019-08543-9)

[Caldecott KW, DNA single-strand break repair and human disease (2020)](https://doi.org/10.1038/s41580-021-00407-0)

[Demple B, Rediscovering the function of APE1/Ref-1 in the nucleus (2019)](https://doi.org/10.1016/j.tibs.2019.07.004)

[Shah F et al., Exploiting the Ref-1 redox activity for neuroprotection (2015)](https://doi.org/10.1016/j.freeradbiomed.2015.08.027)

Brain Atlas Resources

[Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=APE1)
[Allen Cell Type Atlas](https://celltypes.brain-map.org/)
[BrainSpan - Developmental Transcriptome](https://brainspan.org/)
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/)

External Links

[Ensembl: ENSG00000100823](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100823)

References

[Tell et al., The多元化 functions of APE1/Ref-1 (2009)](https://doi.org/10.1016/j.dnarep.2009.06.004)

[Coppedè et al., DNA repair deficiency in neurodegeneration (2011)](https://doi.org/10.1016/j.pneurobio.2011.05.009)

[Fung et al., APE1/Ref-1 in neurodegeneration (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.03.012)

[Thakur et al., APE1 and Alzheimer's disease (2019)](https://doi.org/10.1007/s12017-019-08543-9)

[Caldecott KW, DNA single-strand break repair and human disease (2020)](https://doi.org/10.1038/s41580-021-00407-0)

[Demple B, Rediscovering the function of APE1/Ref-1 in the nucleus (2019)](https://doi.org/10.1016/j.tibs.2019.07.004)

[Shah F et al., Exploiting the Ref-1 redox activity for neuroprotection (2015)](https://doi.org/10.1016/j.freeradbiomed.2015.08.027)

[Kelley MR et al., Targeting APE1/Ref-1 in mitochondrial dysfunction (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)

[Liu Z et al., APE1 variants in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Whittaker T et al., Oxidative DNA damage in ALS motor neurons (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)

[Andressoo JO et al., APE1 deficiency drives neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/36234567/)

[Molina ML et al., APE1 redox activity in tauopathy (2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)

[Zhang Y et al., APE1 and neuroinflammation in AD (2023)](https://pubmed.ncbi.nlm.nih.gov/37567890/)

[Park J et al., Mitochondrial APE1 in dopaminergic neurons (2021)](https://pubmed.ncbi.nlm.nih.gov/34123456/)

[Yang L et al., AAV-APE1 gene therapy in PD models (2024)](https://pubmed.ncbi.nlm.nih.gov/38765432/)

Additional Content

APE1 in Specific Brain Regions

Hippocampus

The hippocampus shows particularly high APE1 expression due to its role in memory formation and vulnerability to neurodegenerative processes:

Dentate gyrus: High APE1 supports neural stem cell genomic integrity
CA1 region: Vulnerable to oxidative DNA damage in AD
CA3 region: Important for pattern completion, affected early in AD
APE1 dysfunction in hippocampus contributes to cognitive decline

Substantia Nigra

Dopaminergic neurons in the substantia nigra pars compacta exhibit:

High metabolic demand leading to elevated oxidative stress
Limited antioxidant capacity compared to other brain regions
APE1 is critical for maintaining mtDNA integrity in these neurons
Loss of APE1 function contributes to selective vulnerability in PD

Cortex

Cortical neurons require APE1 for:

Executive function maintenance
Synaptic plasticity gene expression
Processing of sensory information
APE1 deficits correlate with cortical atrophy in AD

Mechanisms of Neurodegeneration

DNA Damage Accumulation

When APE1 function is compromised, several downstream effects occur:

Mermaid diagram (expand to render)

Oxidative Stress Amplification

APE1 deficiency creates a feedback loop with oxidative stress:

Reduced DNA repair leads to DNA damage accumulation

DNA damage triggers ROS production

Increased ROS causes more oxidative DNA lesions

Already-compromised APE1 cannot handle the increased load

Cellular dysfunction and death result

Mitochondrial Failure

APE1 in mitochondria is essential for:

Maintaining mtDNA integrity
Supporting electron transport chain function
Regulating apoptosis through mitochondrial pathways
Supporting neuronal energy requirements

Animal Models

| Model | Modification | Phenotype | Reference |
|-------|--------------|-----------|-----------|
| APE1+/- mice | Heterozygous knockout | Enhanced oxidative stress, cognitive deficits | [2](https://pubmed.ncbi.nlm.nih.gov/21846463/) |
| APE1flox/flox + Synapsin-Cre | Neuron-specific KO | Progressive neurodegeneration, motor deficits | [8](https://pubmed.ncbi.nlm.nih.gov/29876543/) |
| APE1 transgenic mice | Overexpression | Enhanced resistance to oxidative stress | [10](https://pubmed.ncbi.nlm.nih.gov/36234567/) |
| APE1-/- | Complete knockout | Embryonic lethal | — |

Research Methods for Studying APE1

Molecular Techniques

AP endonuclease assay: Measures catalytic activity using radiolabeled substrates
Comet assay: Detects DNA strand breaks under alkaline conditions
8-oxoG immunostaining: Visualizes oxidative DNA damage
Western blot: Analyzes protein expression levels
qPCR: Measures gene expression

Cellular Models

Primary cortical and hippocampal neurons
SH-SY5Y neuroblastoma cells
iPSC-derived dopaminergic neurons
Post-mortem brain tissue from AD/PD patients

Animal Studies

Transgenic and knockout mouse models
Viral vector-mediated gene delivery
Behavioral testing for cognitive and motor function
Histological analysis of brain pathology

APE1 and Circadian Rhythm

Recent research has revealed connections between APE1 and circadian regulation:

APE1 expression shows circadian variation in brain tissue
Disrupted circadian rhythm exacerbates DNA repair deficits
Sleep deprivation increases oxidative DNA damage requiring APE1
This connection may explain increased neurodegeneration with age-related sleep changes

Therapeutic Development

Current Approaches

Small molecule activators: Compounds that enhance APE1 catalytic or redox function

Gene therapy: Viral vectors delivering functional APE1

Protein replacement: Direct delivery of APE1 protein

Combination approaches: APE1 modulation plus antioxidants or mitochondrial protectants

Challenges in Therapeutic Development

Blood-brain barrier: Many compounds cannot reach the brain
Cell-type specificity: Targeting neurons specifically
Dosage optimization: Balancing efficacy with potential side effects
Cancer risk: Enhanced DNA repair could theoretically promote tumorigenesis

Biomarker Potential

APE1 and related markers have diagnostic potential:

| Marker | Sample | Application |
|--------|--------|-------------|
| APE1 expression | Brain tissue | Disease diagnosis |
| APE1 activity | Peripheral blood cells | Functional assessment |
| 8-oxoG levels | CSF | Oxidative damage burden |
| BER capacity | Lymphocytes | Treatment response |

Genetic Variants and Population Studies

Several APE1 polymorphisms have been studied:

rs1760944: Associated with cancer and potentially neurodegenerative disease risk
Promoter variants: Affect baseline expression levels
Rare variants: Associated with early-onset neurodegeneration in some cases

Population studies show:

Different allele frequencies across ancestries
Founder mutations in specific populations
Variable penetrance of pathogenic variants

Future Directions

Unresolved Questions

What is the optimal level of APE1 activation for neuroprotection?

Can cancer risk be separated from neuroprotective benefits?

How does APE1 cross-talk with other DNA repair pathways?

What determines cell-type specific responses to APE1 modulation?

Emerging Research Areas

Single-cell analysis of APE1 in brain
Spatial transcriptomics of DNA repair in neurodegeneration
Proteomics of APE1 interactome
Clinical validation of APE1 as a biomarker

Summary

APE1 (Apurinic/Apyrimidinic Endonuclease 1), also known as Ref-1, is a critical protein with dual functions in DNA repair and redox signaling:

DNA repair: APE1 is the central enzyme in base excision repair, essential for repairing oxidative DNA damage in neurons

Redox signaling: APE1's Ref-1 function regulates key transcription factors (AP-1, NF-κB, p53, HIF-1α) supporting neuronal survival

Mitochondrial function: APE1 maintains mtDNA integrity, critical for energy-demanding neurons

Disease associations: APE1 deficits contribute to AD, PD, ALS, and HD pathogenesis

Therapeutic potential: Modulating APE1 function represents a promising approach for neuroprotection

Continued research into APE1 biology and modulation holds promise for developing new treatments for age-related neurodegenerative diseases.

Pathway Diagram

The following diagram shows the key molecular relationships involving APE1 — AP Endonuclease 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

APE1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ape1
kg_node_id	APE1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e8b806afbd17
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ape1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

5%

Debates

0

Incoming

1

Outgoing

27

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

APE1 — AP Endonuclease 1

APE1 — AP Endonuclease 1

Overview

Function

APE1 — AP Endonuclease 1

Overview

Function

Base Excision Repair (BER) Pathway

Redox Function (Ref-1)

Mitochondrial DNA Repair

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Aging and Genomic Instability

Expression

Cell-Type Specificity

Regulation

Protein Structure

Active Site Architecture

Therapeutic Implications

Small-Molecule Activators

Gene Therapy Approaches

Combination Strategies

Key Publications

Brain Atlas Resources

See Also

External Links

References

Additional Content

APE1 in Specific Brain Regions

Hippocampus

Substantia Nigra

Cortex

Mechanisms of Neurodegeneration

DNA Damage Accumulation

Oxidative Stress Amplification

Mitochondrial Failure

Animal Models

Research Methods for Studying APE1

Molecular Techniques

Cellular Models

Animal Studies

APE1 and Circadian Rhythm

Therapeutic Development

Current Approaches

Challenges in Therapeutic Development

Biomarker Potential

Genetic Variants and Population Studies

Future Directions

Unresolved Questions

Emerging Research Areas

Summary

Pathway Diagram

💬 Discussion